Abstract:Background: Chronic kidney disease (CKD) with known valve calcification (VC) places individuals at high risk of cardiovascular disease. The study of VC in CKD is challenging due to the lack of a suitable research model. Here, we established a rat model of multivalve calcification induced by subtotal nephrectomy and a high-phosphate (HP) diet and analyzed the valve characteristics. Methods: We established a CKD model in Sprague-Dawley rats by performing 5/6 nephrectomy (5/6Nx) followed by feeding with chow containing different phosphate concentrations for 8, 12, or 16 weeks. The rats were divided into 4 groups: sham+normal phosphate (NP, 0.9% P), sham+high phosphate (HP, 2.0% P), 5/6Nx+NP, and 5/6Nx+HP. Serum creatinine (Scr), blood urea nitrogen (BUN), parathyroid hormone (PTH), calcium, phosphorus, and 24-h urine protein levels were investigated. Pathological examinations included histological characterization, safranin staining, Alcian blue staining, and von Kossa staining at different time points. Using nanoanalytical electron microscopy, we examined valves from rats in the 5/6Nx+HP and sham+HP groups and detected spherical particles using energy-dispersive spectroscopy (EDS) to observe microscopic changes in the valves. In addition, the calcified tissues were analyzed for phase and crystallization properties using an X-ray powder diffractometer. Results: The rats in the 5/6Nx+HP and 5/6Nx+NP groups presented with increased levels of Scr, BUN, and 24-h urine protein compared with those of the rats in the sham+HP and sham+NP groups. High levels of PTH were observed, and hematoxylin and eosin staining and immunohistochemistry for proliferating cell nuclear antigen showed parathyroid hyperplasia in rats in the 5/6Nx+HP group but not in the 5/6Nx+NP group. In rats in the 5/6Nx+HP group, extracellular matrix glycosylation was observed in the aortic valve in the 12th week and the mitral valve in the 16th week. In the 16th week, chondrocytes appeared in the aortic valve, as confirmed by immunofluorescence and Western blotting. Calcified particles mainly composed of phosphorus and calcium were observed in both the aortic and mitral valves by transmission electron microscopy and scanning electron microscopy (SEM). The main mineral component of the calcified aortic valve particles was hydroxyapatite [Ca5(PO4)3(OH)], as shown by X-ray diffraction. However, there were no obvious differences in heart function between rats in the 5/6Nx+HP and sham+HP groups. Conclusions: Our findings demonstrate that multivalve calcification is involved in CKD following 16-week HP and that hydroxyapatite [Ca5(PO4)3(OH)] is the main component of the calcified aortic valve particles of rats in the 5/6Nx+HP group. Kidney Dis

EFFECT OF VARIATIONS IN PH ON VASCULAR CALCIFICATION IN RATS WITH CHRONIC KIDNEY DISEASE AND THE EXPRESSION OF RUNT-RELATED TRANSCRIPTION FACTOR 2

Calcitriol combined with high‐calcium and high‐phosphorus diet induces vascular calcification model in chronic kidney disease rats

A Rat Model with Multivalve Calcification Induced by Subtotal Nephrectomy and High-Phosphorus Diet

High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats

Vascular Calcification Exacerbates Abnormal Blood Pressure Variability in Chronic Kidney Disease: A “Two-Step” Study in Rats

Inhibitory Effect of Ginkgo Biloba Extract on Vascular Calcification in Rats with Chronic Kidney Disease by ROS-NF-κB Signaling Pathway

High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease

Activation of Arterial Matrix Metalloproteinases Leads to Vascular Calcification in Chronic Kidney Disease

ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease

Altered serum metabolome associated with vascular calcification developed from CKD and the critical pathways

Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2

Alleviating vascular calcification with Bushen Huoxue formula in rats with chronic kidney disease by inhibiting the PTEN/PI3K/AKT signaling pathway through exosomal microRNA-32

[The Effect of Alendronate on Arterial Calcification in Rat Model].

NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease

The Role and Possible Mechanism of Aldosterone in the Vascular Calcification of Rats

Mineral and Bone Metabolism Disorder in an Adenine-Induced Rat Model of Chronic Kidney Disease

Relationship between arginine methylation and vascular calcification

Expression of PiT-1 in hyperphosphatemia induced arterial calcification in chronic renal failure rats

in rats with chronic kidney disease by Intermedin 1 – 53 attenuates vascular calci fi cation upregulation of a-Klotho

[Secondary Hyperuricemia in Chronic Renal Failure Promotes Vascular Calcification in Rats].

Establishment of a sub-chronic model of vascular calcification induced by hypervitaminosis D_3 united with nicotine